Exclusive interview with Dr. Joe Duarte, MD. publisher of “In The Money Options” sharing some of his trading strategies, and current stocks picks. He is the author of “Successful biotech investing” (one of his published books) and biotech stocks have a special place in his heart. A few of the biotech stocks he is currently focused on include Gilead (NASDAQ: GILD) and Emergent Biosolutions Inc. (NYSE: EBS) which are attracting investor attention because of their relation to the Coronavirus.
Gilead entered the spotlight recently with it’s antiviral Remdesivir which is in clinical trials in China, as a possible treatment for the coronavirus. Dr. Joe Duarte is bullish on GILD and believes the stock is now waking up after 5 year slump. Dr. Duarte also is a bullish on Emergent Biosolutions Inc. (NYSE: EBS) which has a strong position in the vaccines space and reported strong earnings last week. From a technical perspective, EBS stock is breaking out to the upside.